Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2025-02-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$58.4m
reported value
-34.3% vs Q3 2024
13positions
93.6%in top 10
1 new
6 added
5 reduced
1 sold out
vs Q3 2024
Options: 2 call positions ($7.9m notional), 0 put positions (— notional) – listed below, not included above.
Holdings, Q4 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS IN ARWR | $13.3m22.78% | Reduced -88.2k |
| BLUEPRINT MEDICINES CORP BPMC | $11.3m19.36% | Added +5.0k |
| KYMERA THERAPEUTICS INC KYMR | $7.4m12.64% | Reduced -25.2k |
| ARVINAS INC ARVN | $6.3m10.79% | Reduced -60.0k |
| BICYCLE THERAPEUTICS PLC BCYC | $3.1m5.32% | Added +40.0k |
| PROTAGONIST THERAPEUTICS INC PTGX | $3.0m5.06% | New |
| REGENXBIO INC RGNX | $2.7m4.58% | Reduced -584.4k |
| IMMATICS N.V IMTX | $2.7m4.55% | Added +40.4k |
| SILENCE THERAPEUTICS PLC SLN | $2.5m4.33% | Added +50.0k |
| ADICET BIO INC COM | $2.4m4.17% | Unchanged |
| PRECISION BIOSCIENCES INC DTIL | $2.0m3.50% | Added +154.6k |
| REPARE THERAPEUTICS INC RPTX | $1.7m2.90% | Added +304.4k |
| SUTRO BIOPHARMA INC COM | $9160.00% | Reduced -762.0k |
Sold out since Q3 2024
| Security | Value then |
|---|---|
| MERUS N V MRUS | $5.9m117.9k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| AMGEN INC AMGN · Call | $6.5m25.0k shares | New |
| ARROWHEAD PHARMACEUTICALS IN ARWR · Call | $1.4m75.0k shares | New |